by Biocross | Nov 27, 2013 | News
The company recently completed a multicenter exploratory study in which seven Spanish hospitals participated, to identify markers of the disease. The study involved 306 patients. More...
by Biocross | Feb 4, 2013 | News
Biocross is a biotechnology company that was created in the National Center for Biotechnology in Madrid, and recently moved to the bioincubator in Boecillo Technology Park (Valladolid). The company has suceeded in identifying key markers in blood samples that serve as...
by Biocross | Oct 17, 2012 | News
Biocross is a biotechnology company that was created in the National Center for Biotechnology in Madrid, and recently moved to the bioincubator in Boecillo Technology Park (Valladolid). The company has suceeded in identifying key markers in blood samples that serve as...
by Biocross | Mar 21, 2012 | News
Early diagnosis a key tool in the fight against disease. It is thus essential that currently available tools are continually improved. Biocross has defined 3 main objectives that will guide the direction of this project. BioCross: Método multiparamétrico para el...
by Biocross | Jul 4, 2011 | News
After nearly six months of inactivity, venture capital firm Ade Sodical, owned by the Junta de Castilla y Leon, has been reactivated with an investment in Biocross. More...
